Medicare Enrolled
Dr. Gauri Sharma, D.O.
Hematology · Walnut Creek, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sharma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sharma?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sharma
Dr. Gauri Sharma is a hematology specialist in Walnut Creek, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sharma performed 4,399 Medicare services across 663 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sharma received a total of $16,664 from 88 pharmaceutical and/or device companies across 740 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sharma is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 14% volume in CA
$16,664 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,399
Medicare services
Top 14% in CA for hematology
663
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,400 | $0 | $1 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
521 | $165 | $310 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $114 | $230 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
195 | $16 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
147 | $14 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
136 | $142 | $400 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
127 | $6 | $20 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
84 | $108 | $220 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
74 | $65 | $175 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 65 | $288 | $600 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
58 | $1,639 | $3,500 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
56 | $40 | $125 |
| New patient office visit, complex (60-74 min) | 44 | $190 | $500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $157 | $500 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 26 | $13 | $30 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
19 | $224 | $617 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
18 | $113 | $625 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $87 | $154 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
11 | $29 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.8% high complexity
69.2% medium
26.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,664
Total received (2018-2024)
Avg $2,381/year across 7 years
Top 37% in CA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
740
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,183 (91.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,211 (7.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$270 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,586
2023
$2,238
2022
$2,551
2021
$2,193
2020
$1,844
2019
$3,090
2018
$2,161
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$263
AstraZeneca Pharmaceuticals LP
$243
Janssen Biotech, Inc.
$187
Lilly USA, LLC
$152
Celgene Corporation
$121
Novartis Pharmaceuticals Corporation
$119
ABBVIE INC.
$117
Merck Sharp & Dohme LLC
$116
Daiichi Sankyo Inc.
$109
Astellas Pharma US Inc
$89
SpringWorks Therapeutics, Inc.
$84
E.R. Squibb & Sons, L.L.C.
$83
TerSera Therapeutics LLC
$62
EMD Serono, Inc.
$60
PUMA BIOTECHNOLOGY, INC.
$59
GENZYME CORPORATION
$51
Genentech USA, Inc.
$48
Spectrum Pharmaceuticals Inc.
$45
Eisai Inc.
$44
BeiGene USA, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$38
JAZZ PHARMACEUTICALS INC.
$36
PharmaEssentia USA Corporation
$32
Immunocore Limited
$31
Incyte Corporation
$28
Deciphera Pharmaceuticals Inc.
$27
Genmab U.S., Inc.
$26
Stemline Therapeutics Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Pharmacosmos Therapeutics Inc.
$24
GlaxoSmithKline, LLC.
$24
SERVIER PHARMACEUTICALS LLC
$23
Kite Pharma, Inc.
$23
ARRAY BIOPHARMA INC
$22
Gilead Sciences, Inc.
$22
Fennec Pharmaceuticals, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$17
Regeneron Healthcare Solutions, Inc.
$17
Octapharma USA, Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 26.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,323
Puma Biotechnology, Inc.
$1,235
Astellas Pharma US Inc
$920
Novartis Pharmaceuticals Corporation
$911
PFIZER INC.
$907
Amgen Inc.
$756
Pharmacyclics LLC, An AbbVie Company
$682
AstraZeneca Pharmaceuticals LP
$527
Seagen Inc.
$494
Takeda Pharmaceuticals U.S.A., Inc.
$483
E.R. Squibb & Sons, L.L.C.
$466
GENZYME CORPORATION
$434
Octapharma USA, Inc.
$392
Merck Sharp & Dohme Corporation
$383
Lilly USA, LLC
$368
Kite Pharma, Inc.
$346
Celgene Corporation
$331
Daiichi Sankyo Inc.
$316
Incyte Corporation
$313
Eisai Inc.
$256
Rigel Pharmaceuticals, Inc.
$228
Alexion Pharmaceuticals, Inc.
$208
GlaxoSmithKline, LLC.
$190
Myovant Sciences Inc.
$180
TerSera Therapeutics LLC
$174
ABBVIE INC.
$168
Genentech USA, Inc.
$162
BeiGene USA, Inc.
$160
EMD Serono, Inc.
$142
Sumitomo Pharma America, Inc.
$142
Exelixis Inc.
$128
Regeneron Healthcare Solutions, Inc.
$124
EISAI INC.
$122
Blueprint Medicines Corporation
$120
Merck Sharp & Dohme LLC
$116
Acrotech Biopharma LLC
$113
Heron Therapeutics, Inc.
$111
Spectrum Pharmaceuticals Inc.
$108
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
Kyowa Kirin, Inc.
$102
Deciphera Pharmaceuticals Inc.
$93
Bayer HealthCare Pharmaceuticals Inc.
$88
JAZZ PHARMACEUTICALS INC.
$88
SpringWorks Therapeutics, Inc.
$84
Ipsen Biopharmaceuticals, Inc
$82
Gilead Sciences, Inc.
$81
Taiho Oncology, Inc.
$68
Clovis Oncology, Inc.
$68
Dendreon Pharmaceuticals LLC
$65
AbbVie, Inc.
$63
PUMA BIOTECHNOLOGY, INC.
$59
Helsinn Therapeutics (U.S.), Inc.
$57
Sirtex Medical Inc
$54
Genmab U.S., Inc.
$53
Stemline Therapeutics Inc.
$53
Aurobindo Pharma USA, Inc.
$47
AVEO Pharmaceuticals, Inc.
$46
SERVIER PHARMACEUTICALS LLC
$43
Lexicon Pharmaceuticals, Inc.
$42
Apellis Pharmaceuticals, Inc.
$40
AbbVie Inc.
$38
ARRAY BIOPHARMA INC
$37
Karyopharm Therapeutics Inc.
$37
Sobi, Inc
$32
PharmaEssentia USA Corporation
$32
Immunocore Limited
$31
Foundation Medicine, Inc.
$29
Pharmacyclics LLC, an AbbVie Company
$29
Adaptive Biotechnologies Corporation
$28
Seattle Genetics, Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
Acceleron Pharma, Inc.
$23
Janssen Pharmaceuticals, Inc
$22
CTI BioPharma Corp.
$21
Servier Pharmaceuticals LLC
$20
Fennec Pharmaceuticals, Inc.
$19
TESARO, Inc.
$19
AMAG Pharmaceuticals, Inc.
$19
Shire North American Group Inc
$19
Sun Pharmaceutical Industries Inc.
$18
RECORDATI_RARE_DISEASES_INC.
$17
Blue Earth Diagnostics Limited
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
MACROGENICS, INC.
$16
Novocure Inc.
$14
Amneal Pharmaceuticals LLC
$13
Advanced Accelerator Applications
$12
Secura Bio, Inc.
$12
Top 3 companies account for 20.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · Aliqopa · Aranesp · Axumin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · CABLIVI · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NETSPOT · NINLARO · Nerlynx · Neulasta · None · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONCASPAR · OPDIVO · OPDUALAG · ORGOVYX · Oncology · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · ROZLYTREK · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematologists within 10 mi
8
Per 100K population
0.7
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - WALNUT CREEK CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sharma is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sharma experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Sharma performed 2,400 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sharma receive payments from pharmaceutical companies?
Yes. Dr. Sharma received a total of $16,664 from 88 companies across 740 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sharma's costs compare to other hematologists in Walnut Creek?
Dr. Sharma's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sharma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Walnut Creek
Browse hematologists in Walnut Creek ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in CA
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in CA
Which CA hematologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology